ArticleAcademic radiology2026
Patients' and Providers' Perspective of a Multi-level Approach to Improve Participation in Low-dose CT for Lung Cancer Screening (Empower LCS): A Mixed-Methods Analysis.
Article in Academic radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06000683 (Empowering Patients' Lung Cancer Screening Uptake), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Empowering Patients' Lung Cancer Screening Uptake (Empower LCS)
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
RATIONALE AND
objectivesLung cancer screening (LCS) utilization remains suboptimal. We examined the experience of patients and primary care providers (PCPs) participating in a multilevel intervention addressing LCS barriers.
methodsEmpower LCS is a single-arm pilot feasibility trial evaluating feasibility, acceptability and potential impact of a multilevel intervention, including a decision aid, patient reminders, PCP electronic medical record (EMR) notifications, and support for health-related social needs (HRSNs) for patients screening positive for HRSNs, to improve LCS completion. Using a mixed-methods design, quantitative surveys assessed the helpfulness of intervention components. Additionally, 11 patients and five PCPs participated in 30-minute semi-structured interviews, analyzed through a theoretically driven thematic approach.
resultsOf 70 participants, 41 completed experience questions at 6-months (mean age 61.7 ± 6.4; 63.4% male). Most patients found the intervention helpful: 61.5% (24/39) decision aid, 67.5% (27/40) patient reminder, and 70.7% (29/41) PCP's EMR notification. Most patients viewed LCS as important and wanted to discuss it with their provider. However, some patients felt providers were hesitant to engage fully or lacked knowledge about LCS eligibility. Patient-reported barriers included scheduling challenges, insurance delays, and smoking-related stigma. Many said Empower LCS increased awareness and motivation. Providers reported routinely discussing smoking history and identified low patient awareness, insurance issues, competing priorities, and patient radiation concerns as barriers. They found the intervention appropriate for primary care, especially with better patient education and EMR notifications.
conclusionBoth patients and providers were receptive to LCS and thought the Empower LCS intervention had the potential to increase LCS in routine practice.
trial registrationThis study is registered at www. CLINICALTRIALS: gov: NCT06000683.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.